Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 82-4927284 · Snapshot of IRS recognition, filing currency, financial health, and governance.
To represent and promote the voice of the common business interest of Microbiome therapeutics and Microbiome-based products to provide guidance and related policies used to seek regulatory clarity on issues including clinical trials designs, endpoint selections, and evidential burdens.
Principal Officer
TOM Fagley
Total Revenue
$375K
FY2025
Total Expenses
$367K
FY2025
Net Assets
$51K
Program Ratio
97.5%
expenses on programs
Employees
0
Volunteers
0
Board Members
2
Voting
2
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.